RU2015114694A - Chitosan-based wound dressing (options) - Google Patents

Chitosan-based wound dressing (options) Download PDF

Info

Publication number
RU2015114694A
RU2015114694A RU2015114694A RU2015114694A RU2015114694A RU 2015114694 A RU2015114694 A RU 2015114694A RU 2015114694 A RU2015114694 A RU 2015114694A RU 2015114694 A RU2015114694 A RU 2015114694A RU 2015114694 A RU2015114694 A RU 2015114694A
Authority
RU
Russia
Prior art keywords
antibiotic
chitosan
glycerin
solvent
acetic acid
Prior art date
Application number
RU2015114694A
Other languages
Russian (ru)
Other versions
RU2613112C2 (en
Inventor
Елена Ивановна Кулиш
Анжела Саматовна Шуршина
Валентина Витальевна Чернова
Марина Викторовна Базунова
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный университет" filed Critical Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный университет"
Priority to RU2015114694A priority Critical patent/RU2613112C2/en
Publication of RU2015114694A publication Critical patent/RU2015114694A/en
Application granted granted Critical
Publication of RU2613112C2 publication Critical patent/RU2613112C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Раневое покрытие, выполненное в виде пленки и содержащее хитозан, глицерин, лекарственное вещество и растворитель, отличающееся тем, что в качестве лекарственного вещества содержит антибиотик цефалоспоринового ряда, а в качестве растворителя содержит раствор уксусной кислоты концентрацией 2% при следующем соотношении компонентов, % мас.:хитозан - 36-38,глицерин - 45-51,антибиотик цефалоспоринового ряда - 3-10,раствор уксусной кислоты - остальное.2. Раневое покрытие, выполненное в виде пленки и содержащее хитозан, глицерин, лекарственное вещество и растворитель, отличающееся тем, что в качестве лекарственного вещества содержит антибиотик аминогликозидного ряда, а в качестве растворителя содержит раствор уксусной кислоты концентрацией 2% при следующем соотношении компонентов, % мас.:хитозан - 36-38,глицерин - 45-51,антибиотик аминогликозидного ряда - 3-10,раствор уксусной кислоты - остальное.3. Покрытие по п. 1, отличающееся тем, что в качестве антибиотика цефалоспоринового ряда используют цефатоксима натриевую соль, цефазолина натриевую соль.4. Покрытие по п. 2, отличающееся тем, что в качестве антибиотика аминогликозидного ряда используют амикацина сульфат и гентамицина сульфат.1. A wound coating made in the form of a film and containing chitosan, glycerin, a medicinal substance and a solvent, characterized in that it contains a cephalosporin antibiotic as a medicinal substance, and as a solvent it contains a solution of acetic acid with a concentration of 2% in the following ratio of components,% wt.: chitosan - 36-38, glycerin - 45-51, cephalosporin antibiotic - 3-10, acetic acid solution - the rest. 2. A wound coating made in the form of a film and containing chitosan, glycerin, a medicinal substance and a solvent, characterized in that it contains an aminoglycoside antibiotic as a medicinal substance, and as a solvent it contains a solution of acetic acid with a concentration of 2% in the following ratio of components, wt%. : chitosan - 36-38, glycerin - 45-51, antibiotic of the aminoglycoside series - 3-10, acetic acid solution - the rest. 3. The coating according to claim 1, characterized in that cefatoxime sodium salt and cefazolin sodium salt are used as an antibiotic of the cephalosporin series. A coating according to claim 2, characterized in that amikacin sulfate and gentamicin sulfate are used as an antibiotic of the aminoglycoside series.

Claims (4)

1. Раневое покрытие, выполненное в виде пленки и содержащее хитозан, глицерин, лекарственное вещество и растворитель, отличающееся тем, что в качестве лекарственного вещества содержит антибиотик цефалоспоринового ряда, а в качестве растворителя содержит раствор уксусной кислоты концентрацией 2% при следующем соотношении компонентов, % мас.:1. A wound coating made in the form of a film and containing chitosan, glycerin, a medicinal substance and a solvent, characterized in that it contains a cephalosporin antibiotic as a medicinal substance, and as a solvent it contains a solution of acetic acid with a concentration of 2% in the following ratio of components,% wt .: хитозан - 36-38,chitosan - 36-38, глицерин - 45-51,glycerin - 45-51, антибиотик цефалоспоринового ряда - 3-10,cephalosporin antibiotic - 3-10, раствор уксусной кислоты - остальное.acetic acid solution - the rest. 2. Раневое покрытие, выполненное в виде пленки и содержащее хитозан, глицерин, лекарственное вещество и растворитель, отличающееся тем, что в качестве лекарственного вещества содержит антибиотик аминогликозидного ряда, а в качестве растворителя содержит раствор уксусной кислоты концентрацией 2% при следующем соотношении компонентов, % мас.:2. A wound coating made in the form of a film and containing chitosan, glycerin, a medicinal substance and a solvent, characterized in that it contains an aminoglycoside antibiotic as a medicinal substance, and as a solvent it contains a solution of acetic acid with a concentration of 2% in the following ratio of components,% wt .: хитозан - 36-38,chitosan - 36-38, глицерин - 45-51,glycerin - 45-51, антибиотик аминогликозидного ряда - 3-10,aminoglycoside antibiotic - 3-10, раствор уксусной кислоты - остальное.acetic acid solution - the rest. 3. Покрытие по п. 1, отличающееся тем, что в качестве антибиотика цефалоспоринового ряда используют цефатоксима натриевую соль, цефазолина натриевую соль.3. The coating according to claim 1, characterized in that cefatoxime sodium salt, cefazolin sodium salt are used as an antibiotic of the cephalosporin series. 4. Покрытие по п. 2, отличающееся тем, что в качестве антибиотика аминогликозидного ряда используют амикацина сульфат и гентамицина сульфат. 4. The coating according to claim 2, characterized in that amikacin sulfate and gentamicin sulfate are used as an antibiotic of the aminoglycoside series.
RU2015114694A 2015-04-20 2015-04-20 Chitosan-based wound covering (versions) RU2613112C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015114694A RU2613112C2 (en) 2015-04-20 2015-04-20 Chitosan-based wound covering (versions)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015114694A RU2613112C2 (en) 2015-04-20 2015-04-20 Chitosan-based wound covering (versions)

Publications (2)

Publication Number Publication Date
RU2015114694A true RU2015114694A (en) 2016-11-10
RU2613112C2 RU2613112C2 (en) 2017-03-15

Family

ID=57267770

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015114694A RU2613112C2 (en) 2015-04-20 2015-04-20 Chitosan-based wound covering (versions)

Country Status (1)

Country Link
RU (1) RU2613112C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109364086A (en) * 2018-11-28 2019-02-22 福建师范大学 Method for improving the bactericidal efficiency of aminoglycoside antibiotics by hypertonic glycerol pretreatment
CN109535496A (en) * 2018-11-13 2019-03-29 黄冈师范学院 A kind of preparation method of degradable water penetration coating membrane

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2707973C1 (en) * 2019-02-15 2019-12-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" Hydrogel material based on a chitosan-containing salt and a method for production thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU8608U1 (en) * 1998-04-22 1998-12-16 Государственный научно-исследовательский институт особо чистых биопрепаратов WOUND COVER "HITOSKIN"
US6121375A (en) * 1999-02-11 2000-09-19 Hydromer, Inc. Gels formed by the interaction of poly(aldehyde) with various substances
RU2519158C1 (en) * 2013-03-28 2014-06-10 Федеральное государственное бюджетное учреждение "Саратовский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения Российской Федерации (ФГБУ "СарНИИТО" Минздрава России) Biodegradable wound coating and method for preparing biodegradable wound coating

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109535496A (en) * 2018-11-13 2019-03-29 黄冈师范学院 A kind of preparation method of degradable water penetration coating membrane
CN109364086A (en) * 2018-11-28 2019-02-22 福建师范大学 Method for improving the bactericidal efficiency of aminoglycoside antibiotics by hypertonic glycerol pretreatment

Also Published As

Publication number Publication date
RU2613112C2 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
HRP20210212T1 (en) Tricyclic compound as anticancer agents
CY1121928T1 (en) PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591004A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
BR112018008880A2 (en) As a TLR7 agonist of the 7- (thiazol-5-yl) pyrrolopyrimidine compound
CL2015003346A1 (en) Cenicriviroc compositions and methods for making and using them
EA201690044A1 (en) NUCLEAR TRANSPORT MODULATORS AND THEIR APPLICATION
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
AR098576A1 (en) PHARMACEUTICAL PRODUCT
RU2016135431A (en) COMPOSITION FOR LOCAL TREATMENT OF THE RAS
NZ733670A (en) Insulin glargine/lixisenatide fixed ratio formulation
AR100618A1 (en) PREPARATION PROCEDURE FOR HUMAN ALBUMIN WITH REDUCED DISSOLVED OXYGEN LEVEL
RU2015114694A (en) Chitosan-based wound dressing (options)
EA201492081A1 (en) (R) -NIFURAL, ITS APPLICATION IN THE TREATMENT OF INFECTIONS AND SYNTHESIS (R) - AND (S) -NIFURAL
MX382596B (en) COMPOSITIONS CONTAINING ARSENIC AND THEIR USE IN TREATMENT METHODS.
PH12018501624A1 (en) A composition comprising pic for treatment of cancer
MY186384A (en) Mixed salts of hydroxyalkane sulfinic acid
MX380576B (en) STABILIZATION OF SORBIC ACID IN BEVERAGE SYRUP.
EA201691825A1 (en) STABILIZED SOLUTION ON THE BASIS OF ACTIVE SUBSTANCES, METHOD FOR OBTAINING A STABILIZED SOLUTION OF ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION ON THE BASIS OF A STABILIZED SOLUTION OF ACTIVE SUBSTANCES (TWO OPTIONS)
BR112017009850A2 (en) compound, composition, and use of an hiv enhancer amount of a compound
JP2017517574A5 (en)
HRP20180178T1 (en) Ketorolac compositions for corneal wound healing
AR116711A1 (en) DERIVATIVES OF 4-PIRAZIN-2-ILMETIL-MORPHOLINA AND THEIR USE AS A MEDICINAL PRODUCT
WO2014145713A3 (en) Aminoglycoside antibiotics with reduced ototoxicity
EA201591226A1 (en) COMPOSITION OF TIACUMICINE COMPOUNDS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180421